Chemed (CHE) Non-Current Deferred Tax Liability: 2009-2024
Historic Non-Current Deferred Tax Liability for Chemed (CHE) over the last 16 years, with FY2024 value amounting to $25.9 million.
- Chemed's Non-Current Deferred Tax Liability fell 6549.72% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year decrease of 6549.72%. This contributed to the annual value of $25.9 million for FY2024, which is 1443.22% down from last year.
- According to the latest figures from FY2024, Chemed's Non-Current Deferred Tax Liability is $25.9 million, which was down 1443.22% from $30.3 million recorded in FY2023.
- In the past 5 years, Chemed's Non-Current Deferred Tax Liability registered a high of $38.6 million during FY2022, and its lowest value of $20.7 million during FY2020.
- For the 5-year period, Chemed's Non-Current Deferred Tax Liability averaged around $27.7 million, with its median value being $25.9 million (2024).
- In the last 5 years, Chemed's Non-Current Deferred Tax Liability skyrocketed by 6655.74% in 2022 and then plummeted by 2147.46% in 2023.
- Chemed's Non-Current Deferred Tax Liability (Annual) stood at $20.7 million in 2020, then increased by 12.19% to $23.2 million in 2021, then soared by 66.56% to $38.6 million in 2022, then decreased by 21.47% to $30.3 million in 2023, then decreased by 14.43% to $25.9 million in 2024.
- Its Non-Current Deferred Tax Liability was $25.9 million in FY2024, compared to $30.3 million in FY2023 and $38.6 million in FY2022.